Replies to post #349824 on Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

And, that's a pretty good thing. ;) Thanks for posting it. A good reminder.




Message in reply to:

Brilacidin’s ability to disrupt viral integrity suggests Brilacidin likely is not subject to resistance developing due to coronavirus variants—unlike current COVID-19 treatments, such as monoclonal antibodies and convalescent plasma, and first-generation COVID-19 vaccines. This mechanism of action supports Brilacidin as a clearly differentiated antiviral in clinical development.